Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Olivier Brandicourt
Biotech
GI toxicity hits midstage Sanofi GLP-1 drug as patients drop out
Sanofi says its GLP-1 drug SAR425899 is undertaking new tests to try to get around dosing issues that is causing GI problems.
Ben Adams
Apr 27, 2018 10:02am
Chutes & Ladders—Allergan lures new CFO from Catalent
Feb 9, 2018 3:22am
Chutes & Ladders—Sanofi Genzyme’s chief bows out
Apr 6, 2017 3:42pm
